21.02.2023 Aufrufe

[Elizabeth_Zeibig]_Clinical_Parasitology__A_Practi(z-lib.org)

Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.

YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.

C H A P T E R

3

The Amebas

Hassan Aziz and Elizabeth Zeibig

W H A T ’ S A H E A D

Focusing In

Morphology and Life Cycle

Notes

Laboratory Diagnosis

Pathogenesis and Clinical

Symptoms

Classification of the Amebas

Entamoeba histolytica

Entamoeba hartmanni

Entamoeba coli

Entamoeba polecki

Endolimax nana

Iodamoeba bütschlii

Entamoeba gingivalis

Naegleria fowleri

Acanthamoeba species

Looking Back

L E A R N I N G O B J E C T I V E S

On completion of this chapter and review of

its figures and corresponding photomicrographs,

the successful learner will be able to:

3-1. Define the following key terms:

Acanthopodia

Ameba (pl., amebas)

Amebiasis

Amebic

Amebic colitis

Amebic dysentery

Chromatoid bars

Cyst (pl., cysts)

Encystation

Excystation

Extraintestinal

Flagellum (pl., flagella)

Flagellate (pl., flagellates)

Glycogen mass

Karyosome (karyosomal chromatin)

Kernig’s sign

Pathogenicity

Peripheral chromatin

Pseudopod (pl., pseudopods)

Trophozoite (pl., trophozoites;

often abbreviated as troph

or trophs)

Vector (pl., vectors)

3-2. State the geographic distribution of the

amebas.

3-3. Given a list of parasites, select those

organisms belonging to the protozoan

group Ameba, subphylum Sarcodina.

3-4. Classify the individual ameba as intestinal

or extraintestinal.

3-5. Construct, describe, and compare and

contrast the following life cycles:

A. General intestinal amebas

B. General extraintestinal amebas

C. Each specific ameba

3-6. Briefly identify and describe the populations

prone to contracting clinically significant

disease processes and clinical signs and

symptoms associated with each pathogenic

ameba.

3-7. Identify and describe each of the following

as they relate to the amebas:

A. Factors responsible for the

asymptomatic carrier state of an

infected patient

B. Treatment options

C. Prevention and control measures

3-8. Determine specimen(s) of choice, alternative

specimen type(s) when appropriate,

collection protocol(s), and laboratory

Copyright © 2013 by Saunders, an imprint of Elsevier Inc.

41

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!